References

  1. Suzanne G. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. International Journal of Antimicrobial Agents. 2008 Feb; 31 Suppl 1: S54-7. PubMed | Google Scholar

  2. Hirji I, Guo Z, Andersson S, Hammar N and Gomez-Caminero A. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database. J Diab Comp. 2012 Nov-Dec; 26(6): 513-6. PubMed | Google Scholar

  3. Walsh C, Collyns T. The pathophysiology of Urinary tract infections. Surgery. June 2017; 35(6): 293-298. Google Scholar

  4. World Health Organization. Retrieved from World Health Organization website. 2017. Accessed 5th February 2018.

  5. Hall V, Thomsen R, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications: a systematic review. BMC Public Health. 2011; 11: 564. PubMed | Google Scholar

  6. Hamdan H, Kubbara E, Adam A, Hassan O, Sulman S, Adam I. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microb Antimicr. 2015; 14: 26. PubMed | Google Scholar

  7. Cheesbrough M. District Laboratory Practice in Tropical Countries. 2010: London: Cambridge University Press.

  8. Erika M. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014 Apr; 20(4): O255-66. PubMed | Google Scholar

  9. Al-Rubeaan K, Moharram O, Al-Naqeb D, Hassan A, Rubbean HA. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013; 31(3): 573-578. PubMed | Google Scholar

  10. Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University specialized hospital, Southwest Ethiopia. Ethiopian J Health Sci. 2011; 21(2): 141-146. PubMed | Google Scholar

  11. Ghenghesh K, Rahouma A, Tawil K, Zorgani A, Franka E. Antimicrobial resistance in Libya: 1970-2011. Lybian J Med. 2013; 8: 1-8. PubMed | Google Scholar

  12. Fasugba O, Mitchel B, Mnatzaganian G, Das A, Collignon P, Gardner A. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data. PLoS ONE. 2016; 11(10): 1-14. PubMed | Google Scholar

  13. Yakubov R, Akker M, Machamad K, Hochberg A, Nadir E, Klein A. Antimicrobial resistance among uropathogens that cause childhood community-acquired urinary tract infections in central Israel. Pediatric Inf Dis J. 2017; 36(1): 113-115. PubMed | Google Scholar

  14. Bryce A, Hay A, Lane I, Thornton H, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. Brit Med J. 2016; 352: i939. PubMed | Google Scholar

  15. Jombo G, Emanghe U, Amefule E, Damen J. Nosocomial and community acquired uropathogenic isolates of Proteus mirabilis and antimicrobial susceptibility profiles at a university hospital in Sub-Saharan Africa. Asian Pacific J Trop Dis. 2012; 2(1): 7-11. Google Scholar

  16. Sugianli A, Ginting F, Kusumawati L, Pranggono E, Pasaribu A, Gronthoud F, Geerlings S, Parwati I, De Jong M, Leth F, Schultsz C. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia. J Antimicr Chemo. 2017 May 1; 72(5): 1469-1477. PubMed | Google Scholar